The Market Impact of the COVID-19 Pandemic on the Pharma Industry
By

An upcoming DCAT webinar, featuring Graham Lewis, Vice President, Global Pharma Strategy, IQVIA, evaluates the market impact on the COVID-19 pandemic on companies’ pipelines, product launches, and performance and how industry fundamentals and growth prospects have been affected.

The 90-minute interactive webinar, “Pipelines, Product Launches, and Performance: The Market Impact of COVID-19 on the Pharma Industry,” will be held on Tuesday October 27, 2020 from 11:00 AM to 12:30 PM ET. It will provide up-to-the-minute market data and analysis on the current state and medium-term outlook of the global pharmaceutical industry. It will delve deeply into these crucial questions: (1) how have industry fundamentals been impacted in terms of growth prospects and product development; (2) what is the impact and projections for new product launches and the industry’s pipeline; and (3) what may be the “new normal” for the pharma industry, and what can the industry expect going forward?

Further information, including how to register, may be found here.

Leave a Reply

Your email address will not be published.